BIOCERES CROP SOLUTIONS CORP. Gains Losses On Fair Value Adjustment Biological Assets
BIOCERES CROP SOLUTIONS CORP. (BIOX) reported Gains Losses On Fair Value Adjustment Biological Assets of $131.80 thousand for the 3-month period ending 2025-12-31, per its 6-K filed 2026-03-13.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets · last filed 2026-03-13
- BIOCERES CROP SOLUTIONS CORP. gains losses on fair value adjustment biological assets for the quarter ending 2025-12-31 was $131.80K.
- BIOCERES CROP SOLUTIONS CORP. gains losses on fair value adjustment biological assets for the quarter ending 2025-09-30 was $160.54K, a 75.90% decline year-over-year.
- BIOCERES CROP SOLUTIONS CORP. gains losses on fair value adjustment biological assets for the quarter ending 2025-06-30 was $185.87K.
- BIOCERES CROP SOLUTIONS CORP. gains losses on fair value adjustment biological assets for the quarter ending 2025-03-31 was $990.94K.
| Period end | Gains Losses On Fair Value Adjustment Biological Assets 3 month | Gains Losses On Fair Value Adjustment Biological Assets 6 month | Gains Losses On Fair Value Adjustment Biological Assets 9 month | Gains Losses On Fair Value Adjustment Biological Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $131.80K 6-K · filed 2026-03-13 | $292.34K 6-K · filed 2026-03-13 | $478.21K derived: sum of 3 quarters · filed 2026-03-13 | $1.47M derived: sum of 4 quarters · filed 2026-03-13 |
| 2025-09-30 | $160.54K 6-K · filed 2025-11-26 | $346.41K derived: sum of 2 quarters · filed 2025-11-26 | $1.34M derived: sum of 3 quarters · filed 2025-11-26 | $1.26M derived: sum of 4 quarters · filed 2026-03-13 |
| 2025-06-30 | $185.87K derived: 6-K 12 month − 6-K 9 month · filed 2025-11-26 | $1.18M derived: sum of 2 quarters · filed 2025-11-26 | $1.10M derived: sum of 3 quarters · filed 2026-03-13 | $1.76M 6-K · filed 2025-11-26 |
| 2025-03-31 | $990.94K 6-K · filed 2025-06-20 | $912.82K derived: sum of 2 quarters · filed 2026-03-13 | $1.58M 6-K · filed 2025-06-20 | $1.25M derived: sum of 4 quarters · filed 2026-03-13 |
| 2024-12-31 | -$78.12K 6-K · filed 2026-03-13 | $588.05K 6-K · filed 2026-03-13 | $260.94K derived: sum of 3 quarters · filed 2026-03-13 | $204.18K derived: sum of 4 quarters · filed 2026-03-13 |
| 2024-09-30 | $666.17K 6-K · filed 2025-11-26 | $339.06K derived: sum of 2 quarters · filed 2025-11-26 | $282.30K derived: sum of 3 quarters · filed 2025-11-26 | $209.52K derived: sum of 4 quarters · filed 2025-11-26 |
| 2024-06-30 | -$327.12K derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | -$383.87K derived: sum of 2 quarters · filed 2025-11-10 | -$456.66K derived: sum of 3 quarters · filed 2025-11-10 | -$45.75K 20-F · filed 2025-11-10 |
| 2024-03-31 | -$56.76K 6-K · filed 2025-06-20 | -$129.54K derived: sum of 2 quarters · filed 2025-06-20 | $281.37K 6-K · filed 2025-06-20 | -$80.44K derived: sum of 4 quarters · filed 2025-11-10 |
| 2023-12-31 | -$72.78K 6-K · filed 2025-02-28 | $338.13K 6-K · filed 2025-02-28 | -$23.69K derived: sum of 3 quarters · filed 2025-11-10 | $597.21K derived: sum of 4 quarters · filed 2025-11-10 |
| 2023-09-30 | $410.91K 6-K · filed 2024-11-27 | $49.10K derived: sum of 2 quarters · filed 2025-11-10 | $669.99K derived: sum of 3 quarters · filed 2025-11-10 | $531.46K derived: sum of 4 quarters · filed 2025-11-10 |
| 2023-06-30 | -$361.82K derived: 20-F 12 month − 6-K 9 month · filed 2025-11-10 | $259.08K derived: sum of 2 quarters · filed 2025-11-10 | $120.55K derived: sum of 3 quarters · filed 2025-11-10 | $610.55K 20-F · filed 2025-11-10 |
| 2023-03-31 | $620.89K 6-K · filed 2024-05-29 | $482.37K derived: sum of 2 quarters · filed 2024-05-29 | $972.37K 6-K · filed 2024-05-29 | $3.18M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-12-31 | -$138.53K 6-K · filed 2024-02-28 | $351.48K 6-K · filed 2024-02-28 | $2.56M derived: sum of 3 quarters · filed 2024-10-30 | $4.60M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-09-30 | $490.01K 6-K · filed 2023-11-29 | $2.69M derived: sum of 2 quarters · filed 2024-10-30 | $4.74M derived: sum of 3 quarters · filed 2024-10-30 | $6.33M derived: sum of 4 quarters · filed 2024-10-30 |
| 2022-06-30 | $2.20M derived: 20-F 12 month − 6-K 9 month · filed 2024-10-30 | $4.25M derived: sum of 2 quarters · filed 2024-10-30 | $5.84M derived: sum of 3 quarters · filed 2024-10-30 | $6.39M 20-F · filed 2024-10-30 |
| 2022-03-31 | $2.04M 6-K · filed 2023-05-24 | $3.63M derived: sum of 2 quarters · filed 2023-05-24 | $4.18M 6-K · filed 2023-05-24 | |
| 2021-12-31 | $1.59M 6-K · filed 2023-02-28 | $2.14M 6-K · filed 2023-02-28 | ||
| 2021-06-30 | $2.83M 20-F · filed 2023-11-14 | |||
| 2020-12-31 | $734.83K 6-K · filed 2022-02-25 | $984.19K 6-K · filed 2022-02-25 | ||
| 2020-06-30 | $716.74K 20-F · filed 2022-10-28 | |||
| 2019-12-31 | $719.34K 6-K · filed 2021-02-26 | $719.34K 6-K · filed 2021-02-26 | ||
| 2019-06-30 | $279.94K 20-F · filed 2021-10-29 |